106 related articles for article (PubMed ID: 6674493)
1. [Gas chromatographic separation of the diastereomers of labetalol as n-butylboronate].
Goromaru T; Matsuki Y; Matsuura H; Baba S
Yakugaku Zasshi; 1983 Sep; 103(9):974-8. PubMed ID: 6674493
[No Abstract] [Full Text] [Related]
2. Determination of meprobamate as an n-butylboronate ester derivative in serum by gas-liquid chromatography.
Johansson B; Fromark I
J Chromatogr; 1985 Jun; 341(2):462-4. PubMed ID: 4030991
[No Abstract] [Full Text] [Related]
3. Measurement of myo-inositol in diabetic sera by GC/MS/SIM using n-butylboronate derivatives.
Hasegawa M; Doi K; Baba S
Clin Chim Acta; 1988 Aug; 176(2):207-12. PubMed ID: 3180469
[No Abstract] [Full Text] [Related]
4. Synthesis and comparison of some cardiovascular properties of the stereoisomers of labetalol.
Gold EH; Chang W; Cohen M; Baum T; Ehrreich S; Johnson G; Prioli N; Sybertz EJ
J Med Chem; 1982 Nov; 25(11):1363-70. PubMed ID: 6128421
[TBL] [Abstract][Full Text] [Related]
5. [High performance liquid chromatographic enantiomer separation of beta-blocking agents with a new isothiocyanate type chiral derivatizing agent].
Gyéresi A; Péter M; Fülöp F
Acta Pharm Hung; 2000; 70(3-6):138-45. PubMed ID: 11379020
[TBL] [Abstract][Full Text] [Related]
6. Sensitive high-performance liquid chromatographic method for direct separation of labetalol stereoisomers in biological fluids using an alpha 1-acid glycoprotein stationary phase.
Doroudian A; Yeleswaram K; Rurak DW; Abbott FS; Axelson JE
J Chromatogr; 1993 Sep; 619(1):79-86. PubMed ID: 8245166
[TBL] [Abstract][Full Text] [Related]
7. A gas Chromatographic procedure for quantitation of ethylene glycol in postmortem blood.
Robinson DW; Reive DS
J Anal Toxicol; 1981; 5(2):69-72. PubMed ID: 7242024
[No Abstract] [Full Text] [Related]
8. Antihypertensive aminotetralins related to labetalol and medroxalol.
Clark RD; Caroon JM; Repke DB; Strosberg AM; Whiting RL; Brown CM
J Pharm Sci; 1986 Jan; 75(1):80-2. PubMed ID: 3007731
[TBL] [Abstract][Full Text] [Related]
9. Determination of cyclic butylboronate esters of some 1,2- and 2,3-diols in plasma by high-resolution gas chromatography/mass spectrometry.
Giachetti C; Zanolo G; Assandri A; Poletti P
Biomed Environ Mass Spectrom; 1989 Aug; 18(8):592-7. PubMed ID: 2804444
[TBL] [Abstract][Full Text] [Related]
10. [Separation of enantiomeric labetalol by reversed-phase high performance liquid chromatography].
Zhao H; Li H; Qui Z
Se Pu; 1999 Jul; 17(4):369-71. PubMed ID: 12552853
[TBL] [Abstract][Full Text] [Related]
11. Antihypertensive actions of an isomer of labetalol and other vasodilator-beta-adrenoceptor blockers.
Baum T; Sybertz EJ
Fed Proc; 1983 Feb; 42(2):176-81. PubMed ID: 6130003
[TBL] [Abstract][Full Text] [Related]
12. Labetalol and urinary metadrenalines.
Lax P; Ruthven CR; Sandler M
Br Med J; 1979 Apr; 1(6168):953. PubMed ID: 435897
[No Abstract] [Full Text] [Related]
13. A labetalol metabolite with analytical characteristics resembling amphetamines.
Gilbert RB; Peng PI; Wong D
J Anal Toxicol; 1995; 19(2):84-6. PubMed ID: 7769792
[TBL] [Abstract][Full Text] [Related]
14. N-butylboronate derivatives of the F prostaglandins. Resolution of prostaglandins of the E and F series by gas-liquid chromatography.
Pace-Asciak C; Wolfe LS
J Chromatogr; 1971 Mar; 56(1):129-33. PubMed ID: 5550061
[No Abstract] [Full Text] [Related]
15. Labetalol: false-positive indices by EMIT-d.a.u. assay and Toxi-Lab A urine screen.
Apple FS; Googins MK; Kastner S; Nevala K; Edmondson S; Kloss J
Clin Chem; 1985 Jul; 31(7):1250-1. PubMed ID: 3891145
[No Abstract] [Full Text] [Related]
16. Determination of amosulalol in human plasma using solid-phase extraction combined with liquid chromatography and ultraviolet detection.
Gwak HS; Noh ES; Lee NY; Chun IK
J Chromatogr B Analyt Technol Biomed Life Sci; 2005 Apr; 818(2):109-13. PubMed ID: 15734149
[TBL] [Abstract][Full Text] [Related]
17. Scalp tingling in patients on labetalol.
Hua AS; Thomas GW; Kincaid-Smith P
Lancet; 1977 Aug; 2(8032):295. PubMed ID: 69898
[No Abstract] [Full Text] [Related]
18. Labetalol disposition and concentration-effect relationships during pregnancy.
Rubin PC; Butters L; Kelman AW; Fitzsimons C; Reid JL
Br J Clin Pharmacol; 1983 Apr; 15(4):465-70. PubMed ID: 6849783
[TBL] [Abstract][Full Text] [Related]
19. Labetalol in hypertension.
Breckenridge A; Calvey TN; Green GJ; McIver M; Orme ML; Serlin MJ
Lancet; 1977 Jul; 2(8027):36. PubMed ID: 69119
[No Abstract] [Full Text] [Related]
20. Antihypertensive and hemodynamic actions of SCH 19927, the R,R-isomer and labetalol.
Baum T; Watkins RW; Sybertz EJ; Vemulapalli S; Pula KK; Eynon E; Nelson S; Vliet GV; Glennon J; Moran RM
J Pharmacol Exp Ther; 1981 Aug; 218(2):444-52. PubMed ID: 7252843
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
